Hepatic fibrosis: Concept to treatment - ScienceDirect
Acute-on-chronic liver failure in cirrhosis | Nature Reviews Disease Primers
Nature Reviews Gastroenterology & Hepatology on Twitter: "REVIEW | Gut #microbiota and human #NAFLD: disentangling microbial signatures from metabolic disorders by @ClementLab & colleagues https://t.co/BhjImLZrG0… https://t.co/O3G6TQUOXN"
Nature Reviews Gastroenterology & Hepatology on Twitter: "#TrendingNow @DrLoomba and @ebtapper review the #elastographic assessment of liver fibrosis in #NAFLD and discuss the clinical position of specific techniques £ https://t.co/DSXUwHsBD6… https ...
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease - Gastroenterology
Management of NAFLD: a stage-based approach | Nature Reviews Gastroenterology & Hepatology
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology
Non-alcoholic fatty liver disease - Wikiwand
A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature | American Journal of Physiology-Gastrointestinal and Liver Physiology
Frontiers | The Roles of Liver-Resident Lymphocytes in Liver Diseases | Immunology
MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease in: European Journal of Endocrinology Volume 183 Issue 3 (2020)
Nature Reviews Gastroenterology & Hepatology בטוויטר: "KEY ADVANCE: "The altered gut #microbiota profile is associated with systemic inflammation in patients with nonalcoholic fatty liver disease (#NAFLD)-related cirrhosis who have hepatocellular ...
Liver fibrosis and repair: immune regulation of wound healing in a solid organ | Nature Reviews Immunology
Limitations of non-invasive tests for assessment of liver fibrosis - JHEP Reports
Liver fibrosis: Pathophysiology and clinical implications - Berumen - 2021 - WIREs Mechanisms of Disease - Wiley Online Library
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4-/- mouse model of PFIC3 - Journal of Hepatology
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease | Nature Reviews Nephrology